News Summary
The Allergy & Asthma Network has launched the Patient Advocacy Leadership Initiative (PALI) aimed at empowering patients, caregivers, and families to advocate for healthcare policies. Announced on January 15, 2026, PALI equips over 100 million Americans affected by asthma and allergies with tools to influence local, state, and federal healthcare decisions. Through comprehensive training and direct engagement with policymakers, the program seeks to address systemic barriers in healthcare access and advocate for equal treatment for chronic condition sufferers.
Fairfax, Va.
Allergy & Asthma Network Launches National Patient Advocacy Leadership Initiative (PALI)
The Allergy & Asthma Network has officially launched its new Patient Advocacy Leadership Initiative (PALI), a multifaceted program designed to empower patients, caregivers, and families nationwide to influence healthcare policy at local, state, and federal levels. Announced on January 15, 2026, PALI aims to build a strong community of informed patient advocates ready to drive meaningful change in healthcare decisions affecting millions of Americans living with asthma, allergies, and related conditions.
More than 100 million people across the United States are affected by asthma, allergies, and related health conditions, often facing significant challenges in accessing necessary care and medications. PALI seeks to address these systemic barriers by equipping individuals with the tools and knowledge required to become effective and influential policy advocates. The initiative is a strategic investment in the power of a connected advocacy community, strengthening the collective ability to shape policies that protect health and expand access to care.
Empowering Advocates Through Comprehensive Training
The PALI program provides participants with extensive training and advocacy opportunities crucial for engaging with the legislative process and influencing policy. This training focuses on several key areas to develop well-rounded patient leaders.
Understanding the Legislative Landscape
Participants will gain a clear understanding of how healthcare laws and policies are formulated. This includes learning about the roles of various federal and state agencies in shaping healthcare policy. Such knowledge is vital for navigating the complex environment of healthcare governance and identifying opportunities for patient input.
Developing Advocacy and Communication Skills
A core component of PALI involves building practical skills in advocacy, communication, and storytelling. Advocates will learn to craft compelling, personal advocacy messages suitable for various platforms, including in-person meetings, email correspondence, and social media. The ability to effectively share personal experiences is emphasized as a powerful tool to inspire change and bring real-life perspectives to policymakers.
Direct Engagement with Policymakers
PALI facilitates direct engagement between patients and legislators, staffers, and policymakers. A significant opportunity for participants includes joining the Allergy & Asthma Day Capitol Hill (AADCH), an annual advocacy day in Washington, D.C., which allows advocates to directly present their concerns and stories. The initiative aims to help patients connect with local leaders and ensure their voices are integral to healthcare decisions.
Navigating Key Healthcare Issues
The program educates advocates on crucial issues impacting access to care, treatment, medications, research funding, environmental health, and health equity. This comprehensive understanding allows participants to advocate effectively for policies that support fair and equal care for all people living with chronic conditions.
Building Advocacy Networks
PALI encourages the formation of strong networks among advocates, advocacy organizations, community leaders, and other patient champions. By fostering these connections, the initiative aims to create a sustained, connected community of patient advocacy leaders capable of driving progress on issues affecting millions of Americans.
Leadership Perspectives on PALI’s Impact
Lynda Mitchell, CEO of the Allergy & Asthma Network, highlighted the initiative’s significance. She stated that PALI represents an investment in the strength of a united advocacy community, enhancing the collective ability to shape policies that safeguard health, broaden access to care, and ensure the needs of individuals with asthma, allergies, and related conditions are prioritized in healthcare policy discussions.
Nissa Shaffi, Director of Advocacy at the Allergy & Asthma Network, underscored the invaluable expertise of patients and caregivers. She noted that they are the true experts on how asthma and allergies impact daily life. Shaffi added that PALI provides these individuals with the necessary tools to articulate their issues and a platform to directly share their lived experiences with policymakers, leading to smarter policies, stronger communities, and a healthcare system more responsive to real needs.
A Legacy of Advocacy and Future Vision
Advocacy has been a fundamental part of the Allergy & Asthma Network’s mission since its establishment in 1985. For nearly four decades, the organization has partnered with federal and state agencies, congressional offices, and public health stakeholders. Their advocacy efforts have historically promoted policies that improve access to treatment, strengthen disease management programs, support research funding, and address critical environmental and health equity challenges.
The Allergy & Asthma Network operates as a leading nonprofit organization dedicated to outreach, education, advocacy, and research for individuals managing asthma, allergies, and related conditions. Its profound mission is to advance patient-centered research and champion better outcomes, access to care, education, and treatments that enhance health and quality of life. The network is recognized for its ability to translate medically accurate information into easily understandable content, promoting evidence-based care and fostering collaboration among patients, clinicians, researchers, advocates, and policymakers.
PALI also includes a component to recognize and celebrate individuals who are making a meaningful impact through their advocacy efforts at local, state, or national levels. This recognition aims to inspire others to get involved and drive significant change within their communities. The initiative receives funding through the generous support of sponsors Amgen, AstraZeneca, and Sanofi Regeneron.
Frequently Asked Questions (FAQ)
- What is the Patient Advocacy Leadership Initiative (PALI)?
- The Patient Advocacy Leadership Initiative (PALI) is a multifaceted program launched by the Allergy & Asthma Network. It is designed to build a nationwide network of informed, empowered patient advocates who are ready to influence healthcare policy at local, state, and federal levels.
- When was PALI officially launched?
- PALI was officially launched on January 15, 2026.
- Who is PALI designed to help?
- PALI is designed to help patients, caregivers, and families nationwide who are living with asthma, allergies, and related health conditions.
- What are the main goals of PALI?
- The main goals of PALI include teaching how healthcare laws and policies are made, building skills in advocacy, communication, and storytelling, helping patients connect with policymakers and local leaders, lifting up patient voices in healthcare decisions, and supporting fair and equal care for all people.
- What kind of training does PALI offer?
- PALI offers training in understanding the legislative process, crafting compelling personal advocacy messages, engaging directly with legislators, navigating key issues affecting access to care, treatment, medications, research, environmental health, and health equity, and building networks with other advocacy organizations.
- Does PALI involve direct interaction with policymakers?
- Yes, PALI facilitates direct engagement with legislators, staffers, and policymakers, including participation in Allergy & Asthma Day Capitol Hill (AADCH).
- Who are the sponsors of the PALI initiative?
- PALI is funded through the generous support of sponsors Amgen, AstraZeneca, and Sanofi Regeneron.
Key Features of the Patient Advocacy Leadership Initiative (PALI)
| Feature | Description | Scope |
|---|---|---|
| Core Objective | To build a nationwide network of informed, empowered patient advocates to influence healthcare policy. | Nationwide |
| Target Audience | Patients, caregivers, and families living with asthma, allergies, and related conditions. | Nationwide |
| Training Modules | Understanding legislative processes, crafting advocacy messages, developing communication and storytelling skills. | Nationwide |
| Direct Engagement | Opportunities to engage directly with legislators and policymakers, including participation in Allergy & Asthma Day Capitol Hill (AADCH). | Federal, State, Local |
| Issue Focus | Navigating key issues related to access to care, treatment, medications, research, environmental health, and health equity. | Nationwide |
| Networking | Building connections with other advocates, community leaders, and advocacy organizations. | Nationwide |
| Recognition Component | A component to recognize and celebrate individuals making a meaningful impact through their advocacy efforts. | Local, State, or National |
| Funding Sponsors | Amgen, AstraZeneca, and Sanofi Regeneron. | N/A |
Deeper Dive: News & Info About This Topic
The Impact of Patient Advocacy on Clinical Trials and Healthcare Policy
JDL Access Launches Access Bridge™ Enterprise Case Management Platform
DiMe Launches Nationwide Initiative for AI Care Navigation
Patient Advocacy Groups Push to Halt Overseas Prescription Drug Operations
Johnson County Launches Patient Advocacy Line for Inmates’ Families
Gallagher Bassett Reveals Key Factors for Worker Return-to-Work Success
JDL Access Unveils Access Bridge™ for Case Management
DiMe Launches Initiative to Enhance AI in Patient Care Navigation
CheckedUp Appoints Lyndi Hirsch as Chief Marketing Officer
Federal Immigration Agents Involved in Controversial Hospital Incident